KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Payables (2016 - 2025)

Historic Payables for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $77.3 million.

  • Evolent Health's Payables rose 5432.75% to $77.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.3 million, marking a year-over-year increase of 5432.75%. This contributed to the annual value of $267.5 million for FY2024, which is 45443.35% up from last year.
  • Latest data reveals that Evolent Health reported Payables of $77.3 million as of Q3 2025, which was up 5432.75% from $241.6 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Payables peaked at $267.5 million during Q4 2024, and registered a low of $37.8 million during Q3 2021.
  • Moreover, its 5-year median value for Payables was $64.0 million (2022), whereas its average is $91.8 million.
  • In the last 5 years, Evolent Health's Payables tumbled by 4928.07% in 2024 and then surged by 51895.72% in 2025.
  • Evolent Health's Payables (Quarter) stood at $96.1 million in 2021, then plummeted by 40.5% to $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 454.43% to $267.5 million in 2024, then crashed by 71.1% to $77.3 million in 2025.
  • Its Payables stands at $77.3 million for Q3 2025, versus $241.6 million for Q2 2025 and $229.6 million for Q1 2025.